Home/Filings/4/0001209191-17-025162
4//SEC Filing

AmpliPhi Biosciences Corp 4

Accession 0001209191-17-025162

$ARMPCIK 0000921114operating

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 5:35 PM ET

Size

5.4 KB

Accession

0001209191-17-025162

Insider Transaction Report

Form 4
Period: 2017-04-01
Martin Steven Robert
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-04-01+161,290161,290 total
    Exercise: $0.43Exp: 2021-03-31Common Stock (161,290 underlying)
Footnotes (1)
  • [F1]The shares subject to the option are 100% vested and exercisable as of the date of grant.

Issuer

AmpliPhi Biosciences Corp

CIK 0000921114

Entity typeoperating
IncorporatedWA

Related Parties

1
  • filerCIK 0000921114

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 5:35 PM ET
Size
5.4 KB